Yusra et al. (28) found that the expression of TGFBR1 and TGFBR3 was higher in CD133-positive colon cancer stem cells, suggesting that CD133+ CCSCs have an increased sensitivity to TGF-β. Here, TGFBR1 is linked to malignant colon neoplasm.